Summary
Updated Aug 31, 2026
James E. Levine is Chief Financial Officer of KAZIA THERAPEUTICS LTD (KZIA). 2 SEC Form 4 filings on record going back to 2024, most recently on 23 June 2026. Most recent open-market trade: bought $12K of CRDF on 18 December 2024. Lifetime open-market purchases: $37K. Historical track record: 1/5 stars across 3 tracked purchases.
Recent Transactions
3Every recent SEC Form 4 transaction James E. Levine has reported, most recent first.
Track Record
InsiderAlpha computes a forward-return-based score for every insider with enough Form 4 purchase history. The metrics below reflect realized performance after each tracked open-market purchase.
| Metric | Value |
|---|---|
| InsiderAlpha rating | ★☆☆☆☆ (1/5) |
| Total purchases tracked | 3 |
| Purchases with forward-return data | 3 |
| 30-day win rate | 0% |
| 90-day win rate | 33% |
| Avg 5-day return | -10.76% |
| Avg 30-day return | -24.75% |
| Avg 90-day return | -13.13% |
| Best 30-day return | -14.64% |
Trading Pattern
InsiderAlpha's records for James E. Levine go back to 2024: 2 primary Form 4 filings, an average of 0.7 per year. The typical open-market purchase is $12K (3 buys totaling $37K). The largest single buy on record is $15K of CRDF in 2024. No transaction on record carries a Rule 10b5-1 flag - the filings look discretionary rather than pre-scheduled, which makes their timing more informative as a signal.
Most Active Insiders Right Now
James E. Levine has no co-filers on record, so these are insiders with the largest open-market activity across the market in the last 90 days.
- BDT CAPITAL PARTNERS, LLC - $589.61M of ALH open-market activity in the last 90 days
- Joseph Gebbia - $510.90M of ABNB open-market activity in the last 90 days
- ORCP III DE TopCo GP, LLC - $497.40M of PRMB open-market activity in the last 90 days
- Tony W. Lee - $497.40M of PRMB open-market activity in the last 90 days
- Argon Holdco LLC - $491.11M of CRBG open-market activity in the last 90 days
- Niccolo Camerana - $478.31M of STNG open-market activity in the last 90 days
More Notable Insiders
Other corporate insiders with significant SEC Form 4 track records on InsiderAlpha:
Frequently Asked Questions
Who is James E. Levine?
James E. Levine is a corporate insider, tracked as Chief Financial Officer of KAZIA THERAPEUTICS LTD (KZIA). InsiderAlpha holds 2 primary Form 4 filings for them, the earliest from 2024, updated as new SEC EDGAR filings are processed.
How many SEC Form 4 filings has James E. Levine submitted recently?
1 primary Form 4 filing in the last 90 days, covering 1 company.
Has James E. Levine been buying or selling stock?
Recorded transactions: 3 open-market purchases ($37K) and 0 open-market sales across all tracked filings.
How accurate is James E. Levine's historical track record?
Across 3 tracked purchases, James E. Levine averaged -24.8% avg 30-day return with a 0% 30-day win rate. InsiderAlpha rates the track record at 1/5 stars.
Where can I see all of James E. Levine's SEC filings?
All Form 4 filings, transaction values, and 10b5-1 plan flags are listed on this page and updated in real time as new SEC EDGAR filings are processed.
Learn More
Follow James E. Levine and every insider like them
A free account opens the full scored daily plan and every past day, a watchlist for any ticker, and 3 months of price history on every company page. No card.
Free plan available · Paid plans start with a 7-day free trial